ICD-10-CM Billable Code

C50.821

Malignant neoplasm of overlapping sites of right male breast

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of overlapping sites of the right male breast refers to a type of breast cancer occurring in men, characterized by tumors that span multiple overlapping areas within the right breast. Though breast cancer is commonly associated with women, men can also develop this condition. This diagnosis indicates that the cancer affects more than one specific part of the breast tissue, making it a complex and serious health concern requiring prompt medical attention.

Causes & Symptoms

Clinical Causes: Genetic factors, such as mutations in BRCA1 or BRCA2 genes Family history of breast cancer Hormonal imbalances leading to increased estrogen levels Exposure to radiation or environmental carcinogens Age, with higher risk in older men Certain benign breast diseases that may increase malignancy risk

Key Symptoms: Lump or thickening in the breast tissue Skin changes on the breast, such as dimpling or redness Nipple retraction or discharge, particularly if bloody Persistent pain in the breast or nipple area Swelling or a palpable mass in the breast Ulceration or skin ulcer over the affected area

Diagnostic & Treatment

Diagnosis Path: Physical examination to assess lumps, skin, and nipple changes Mammography or ultrasound imaging to visualize abnormalities Biopsy — removing a tissue sample for laboratory analysis Magnetic resonance imaging (MRI) if additional details are needed Laboratory tests to evaluate hormone receptor status and molecular characteristics

Treatment Protocols: Surgical removal of the tumor, which might involve mastectomy or breast-conserving surgery Radiation therapy to target residual cancer cells Chemotherapy to kill or inhibit the growth of cancer cells Hormone therapy if the tumor is hormone receptor-positive Targeted therapy to attack specific molecules involved in tumor growth Supportive care and follow-up monitoring to manage side effects and detect recurrence

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.821 a billable ICD-10 code?
Yes, C50.821 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.821?
Clinical documentation must specify the nature of Malignant neoplasm of overlapping sites of right male breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference